Nao Nishimura

511 total citations
46 papers, 335 citations indexed

About

Nao Nishimura is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Nao Nishimura has authored 46 papers receiving a total of 335 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 14 papers in Pulmonary and Respiratory Medicine and 11 papers in Surgery. Recurrent topics in Nao Nishimura's work include Multiple Myeloma Research and Treatments (7 papers), Respiratory Support and Mechanisms (5 papers) and Airway Management and Intubation Techniques (4 papers). Nao Nishimura is often cited by papers focused on Multiple Myeloma Research and Treatments (7 papers), Respiratory Support and Mechanisms (5 papers) and Airway Management and Intubation Techniques (4 papers). Nao Nishimura collaborates with scholars based in Japan, Egypt and United States. Nao Nishimura's co-authors include Satoshi Nakagawa, Shinya Endo, Yutaka Okuno, Hiroaki Mitsuya, Yasuhisa Mizutani, Hideki Kandori, Mureo Kasahara, Hiroyuki Hata, Misao Mizuno and Naoko Wada and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and The Journal of Physical Chemistry B.

In The Last Decade

Nao Nishimura

41 papers receiving 332 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nao Nishimura Japan 10 120 65 57 50 45 46 335
Soumitra Tole Canada 9 104 0.9× 30 0.5× 23 0.4× 52 1.0× 50 1.1× 20 339
Ashish O. Gupta United States 13 180 1.5× 49 0.8× 52 0.9× 40 0.8× 80 1.8× 77 473
José María Hernández Pérez Spain 12 55 0.5× 82 1.3× 140 2.5× 96 1.9× 33 0.7× 63 421
Christine Lombard France 12 72 0.6× 54 0.8× 42 0.7× 36 0.7× 31 0.7× 33 412
David Heinzmann Germany 13 208 1.7× 95 1.5× 24 0.4× 45 0.9× 24 0.5× 29 668
Yufeng Shang China 10 131 1.1× 108 1.7× 38 0.7× 27 0.5× 46 1.0× 30 443
Maria Giuseppina Cefalo Italy 14 76 0.6× 85 1.3× 52 0.9× 35 0.7× 133 3.0× 43 407
Elisabet Tina Sweden 12 132 1.1× 71 1.1× 64 1.1× 36 0.7× 10 0.2× 23 353
Mohammad Amin Habibi Iran 10 34 0.3× 45 0.7× 48 0.8× 58 1.2× 18 0.4× 125 371

Countries citing papers authored by Nao Nishimura

Since Specialization
Citations

This map shows the geographic impact of Nao Nishimura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nao Nishimura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nao Nishimura more than expected).

Fields of papers citing papers by Nao Nishimura

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nao Nishimura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nao Nishimura. The network helps show where Nao Nishimura may publish in the future.

Co-authorship network of co-authors of Nao Nishimura

This figure shows the co-authorship network connecting the top 25 collaborators of Nao Nishimura. A scholar is included among the top collaborators of Nao Nishimura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nao Nishimura. Nao Nishimura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kawano, Yawara, Nao Nishimura, & Jun‐ichirou Yasunaga. (2024). Serum monoclonal immunoglobulin light-chain detection differs between immunofixation electrophoresis methods in patients with AL amyloidosis. International Journal of Hematology. 120(2). 212–216.
2.
Shoji, Kensuke, et al.. (2023). The Utility of Performing Anaerobic Blood Cultures in Pediatric Intensive Care Units. Journal of the Pediatric Infectious Diseases Society. 12(6). 372–378. 1 indexed citations
3.
4.
Masuda, Hiroshi, et al.. (2022). Plasma exchange and infliximab as a third‐line therapy for refractory infantile Kawasaki disease. Pediatrics International. 64(1). e15226–e15226. 1 indexed citations
5.
Matsui, Hikoro, et al.. (2022). Inappropriately home‐prepared paste food causing methemoglobinemia in children. Pediatrics International. 64(1). e15134–e15134. 1 indexed citations
6.
Nishimura, Nao, et al.. (2022). Pulmonary hypertension caused by vitamin C deficiency in a 2‐year‐old girl. Pediatrics International. 64(1). e14971–e14971. 2 indexed citations
7.
Sakamoto, Kenichi, et al.. (2021). Life‐threatening oral mucositis following chemotherapy in a pediatric patient. SHILAP Revista de lepidopterología. 9(6). e04356–e04356. 2 indexed citations
8.
Nishimura, Nao, et al.. (2021). Effect of sodium–chloride ion difference on pH regulation. Clinical Biochemistry. 96. 75–77.
9.
10.
Imamura, Tadatsugu, Kensuke Shoji, Naoko Kono, et al.. (2020). Allele frequencies of Bordetella pertussis virulence-associated genes identified from pediatric patients with severe respiratory infections. Journal of Infection and Chemotherapy. 26(7). 765–768. 5 indexed citations
11.
Tsuji, Satoshi, et al.. (2020). Upper airway obstruction in an adolescent: Can airway foreign bodies be missed without self-reporting?. Respiratory Medicine Case Reports. 29. 101029–101029. 3 indexed citations
12.
Matsumoto, Shotaro, et al.. (2019). Fluid dynamics approach to airway obstruction. Medical Hypotheses. 132. 109341–109341. 5 indexed citations
13.
Hata, Hiroyuki, Mitsuharu Ueda, Nao Nishimura, et al.. (2017). Amyloid Fibril Formation of Immunoglobulin Light Chain Peptide from IHC-Negative AL Amyloidosis and Its Inhibition By Doxycycline and Epigallocatechin. Blood. 130. 5331–5331. 1 indexed citations
14.
Nishimura, Nao, Shinya Endo, Shiho Fujiwara, et al.. (2017). Identification of a Compound Overcoming Drug Resistance of Myeloma Cells at Hypoxic Condition. Blood. 130. 5395–5395. 1 indexed citations
15.
Nishimura, Nao, Shinya Endo, Shikiko Ueno, et al.. (2017). A xenograft model reveals that PU.1 functions as a tumor suppressor for multiple myeloma in vivo. Biochemical and Biophysical Research Communications. 486(4). 916–922. 2 indexed citations
16.
Nishimura, Nao, Shikiko Ueno, Shinya Endo, et al.. (2017). PU.1 acts as tumor suppressor for myeloma cells through direct transcriptional repression of IRF4. Oncogene. 36(31). 4481–4497. 27 indexed citations
17.
Nishimura, Nao, Mureo Kasahara, Kenji Ishikura, & Satoshi Nakagawa. (2017). Current status of pediatric transplantation in Japan. Journal of Intensive Care. 5(1). 48–48. 17 indexed citations
18.
Ide, Kentaro, et al.. (2016). Pediatric tracheostomy: Survival and long-term outcomes. International Journal of Pediatric Otorhinolaryngology. 89. 81–85. 18 indexed citations
19.
Endo, Shinya, Masayuki Amano, Nao Nishimura, et al.. (2015). Immunomodulatory drugs act as inhibitors of DNA methyltransferases and induce PU.1 up-regulation in myeloma cells. Biochemical and Biophysical Research Communications. 469(2). 236–242. 12 indexed citations
20.
Nakano, Kenji, Takeshi Yuasa, Nao Nishimura, et al.. (2012). Feasibility and Efficacy of Combined Cisplatin and Irinotecan Chemotherapy for Poorly Differentiated Neuroendocrine Carcinomas. Japanese Journal of Clinical Oncology. 42(8). 697–703. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026